The possible explanation was that patients with stage IIIA were all triple negative breast cancer (ER, PR, and HER2) in our study population, which is highly invasive and more prone to have distant metastasis than other molecular types, and the value of locoregional RT cannot be reflected [26, 27]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.